Experic, a Cranbury, NJ-based contract development and manufacturing organization (CDMO) and clinical supply services company, raised an undisclosed amount in Series B extension.
The backers were not disclosed.
The company intends to use the funds to bolster its presence in the biopharmaceutical industry by expanding its service offerings and making strategic investments in its previously announced analytical laboratory and spray drying capabilities.
Led by David Wood, CEO, Experic supports all the phases of a product’s life cycle from conception to clinical and commercial scale, across a range of dosing and packaging formats, including tablets, pellets, capsules, and low dose dry powder inhalation. From its Class A cGMP facility, the company manages global delivery of products, even for expedited projects, while providing knowledge, expertise, and customer service.
FinSMEs
05/10/2023